GlassScriptPhysician profile
Madison Loruss
NPI 1720864382
$602.21
in general payments reported to CMS, 2019-2025
11 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $126 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $180.39 | 2025 | Apligraf, Puraply Wound Matrix, Cygnus Matrix |
| Tactile Systems Technology INC | $122.59 | 2025 | Nimbl, Flexitouch Plus |
| Solventum Corporation | $62.36 | 2024-2025 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Smith+Nephew, INC. | $58.01 | 2024-2025 | Collagenase Santyl, Stravix Pl |
| Mimedx Group, INC. | $55.71 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $34.78 | 2025 | Nuzyra |
| Convatec INC. | $24.71 | 2025 | |
| Reprise Biomedical, INC. | $20.79 | 2025 | Miro3d |
| Urgo Medical North America, LLC | $14.93 | 2024 | Urgok2 |
| Integra Lifesciences Corporation | $14.42 | 2024 | Tcc-Ez |
| Surgenex LLC | $13.52 | 2025 | Surgraft, Surmatrix, Pellograft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Loruss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.